Research Article
Optimal Strategy for Colorectal Cancer Patients’ Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9
Figure 3
CTC (a), CTEC (b), CEA (c), and CA19-9 (d) levels between healthy controls and CRC patients.
(a) |
(b) |
(c) |
(d) |